Insider Trading activities of Rhythm Pharmaceuticals, Inc. (RYTM)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rhythm Pharmaceuticals, Inc. (RYTM) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rhythm Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Rhythm Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is RYTM. The reporting company's CIK number is 1649904.
The total value of stock buying since 2005 is $106,760,000.
The total value of stock sales since 2005 is $25,333,154.
The total value of stock option exercises since 2005 is $752,363.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rhythm Pharmaceuticals, Inc. (RYTM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-12 0 $0 123,539 $2,986,232 0 $0
2019-11 0 $0 557,857 $12,473,951 0 $0
2019-08 0 $0 0 $0 14,534 $99,993
2019-07 0 $0 0 $0 17,500 $103,225
2019-05 0 $0 25,000 $633,400 25,000 $122,500
2019-03 0 $0 19,578 $588,827 0 $0
2019-02 0 $0 19,303 $579,475 0 $0
2019-01 0 $0 26,756 $803,586 3,000 $20,640
2018-12 0 $0 563 $16,890 0 $0
2018-11 0 $0 54,500 $1,639,740 28,200 $171,540
2018-09 0 $0 31,800 $945,096 24,800 $120,702
2018-08 0 $0 0 $0 14,534 $99,993
2018-05 0 $0 151,216 $4,665,957 3,000 $13,770
2017-10 6,280,000 $106,760,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rhythm Pharmaceuticals, Inc. insiders (RYTM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-12-12 Foley Todd (Director) Sale 3,762 25.01 94,087
2019-12-11 Foley Todd (Director) Sale 13,600 25.14 341,904
2019-12-10 Foley Todd (Director) Sale 41,839 25.36 1,061,037
2019-12-09 Foley Todd (Director) Sale 22,195 25.04 555,762
2019-12-03 Foley Todd (Director) Sale 16,777 22.33 374,630
2019-12-02 Foley Todd (Director) Sale 25,366 22.03 558,812
2019-11-29 Foley Todd (Director) Sale 18,359 22.67 416,198
2019-11-27 Foley Todd (Director) Sale 34,960 22.91 800,933
2019-11-26 Foley Todd (Director) Sale 74,225 23.31 1,730,184
2019-11-25 Foley Todd (Director) Sale 121,343 23.19 2,813,944
2019-11-22 Foley Todd (Director) Sale 102,682 21.91 2,249,762
2019-11-21 Foley Todd (Director) Sale 64,923 20.80 1,350,073
2019-11-20 Foley Todd (Director) Sale 141,365 22.02 3,112,857
2019-08-12 Desikan Nithya (Chief Commercial Officer) Option Ex 14,534 6.88 99,993
2019-07-16 Gottesdiener Keith Michael (CEO and President) Option Ex 7,500 4.59 34,425
2019-07-11 Smith Hunter C (Chief Financial Officer) Option Ex 10,000 6.88 68,800
2019-05-31 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 5,000 25.10 125,500
2019-05-31 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 5,000 4.59 22,950
2019-05-30 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 5,000 25.31 126,550
2019-05-30 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 5,000 4.59 22,950
2019-05-29 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 5,000 25.51 127,550
2019-05-29 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 5,000 4.59 22,950
2019-05-28 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 10,000 25.38 253,800
2019-05-28 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 10,000 5.37 53,650
2019-03-18 Gottesdiener Keith Michael (CEO & President) Sale 2,329 30.27 70,498
2019-03-15 Gottesdiener Keith Michael (CEO & President) Sale 7,961 30.04 239,148
2019-03-14 Gottesdiener Keith Michael (CEO & President) Sale 1,506 30.05 45,255
2019-03-13 Gottesdiener Keith Michael (CEO & President) Sale 7,782 30.06 233,926
2019-02-27 Gottesdiener Keith Michael (CEO and President) Sale 1,814 30.01 54,438
2019-02-26 Gottesdiener Keith Michael (CEO and President) Sale 635 30.13 19,132
2019-02-19 Gottesdiener Keith Michael (CEO and President) Sale 918 30.05 27,585
2019-02-15 Gottesdiener Keith Michael (CEO and President) Sale 12,002 30.02 360,300
2019-02-13 Gottesdiener Keith Michael (CEO and President) Sale 3,934 30.00 118,020
2019-01-31 Smith Hunter C (Chief Financial Officer) Option Ex 3,000 6.88 20,640
2019-01-23 Gottesdiener Keith Michael (CEO and President) Sale 105 30.21 3,172
2019-01-22 Gottesdiener Keith Michael (CEO and President) Sale 15,674 30.05 471,003
2019-01-18 Gottesdiener Keith Michael (CEO & President) Sale 10,115 30.01 303,551
2019-01-16 Gottesdiener Keith Michael (CEO & President) Sale 662 30.00 19,860
2019-01-16 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 200 30.00 6,000
2018-12-03 Gottesdiener Keith Michael (CEO and President) Sale 563 30.00 16,890
2018-11-02 Gottesdiener Keith Michael (CEO and President) Sale 16,500 30.08 496,320
2018-11-02 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 38,000 30.09 1,143,420
2018-11-02 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 28,200 6.08 171,540
2018-09-25 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 31,800 29.72 945,096
2018-09-25 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 21,800 4.59 100,062
2018-09-05 Smith Hunter C (Chief Financial Officer) Option Ex 3,000 6.88 20,640
2018-08-10 Desikan Nithya (Chief Commercial Officer) Option Ex 14,534 6.88 99,993
2018-05-22 Orbimed Capital Gp V Llc Sale 19,580 30.67 600,518
2018-05-21 Orbimed Capital Gp V Llc Sale 62,500 31.01 1,938,125
2018-05-18 Orbimed Capital Gp V Llc Sale 69,136 30.77 2,127,314
2018-05-09 Gottesdiener Keith Michael (C.E.O. and President) Option Ex 3,000 4.59 13,770
2017-10-10 Deerfield Private Design Fund Iii, L.p. Buy 355,000 17.00 6,035,000
2017-10-10 Mpm Bioventures V Llc (10% Owner) Buy 100,000 17.00 1,700,000
2017-10-10 Viswanathan Ravi (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Foley Todd (Director) Buy 100,000 17.00 1,700,000
2017-10-10 Nea 13 Gp, Ltd (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Meeker David P (Director) Buy 25,000 17.00 425,000
2017-10-10 Ipsen, S.a. (10% Owner) Buy 20,000 17.00 340,000
2017-10-10 Baskett Forest (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Sandell Scott D (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Kerins Patrick J (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Mott David M (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Barrett M James (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Isaly Samuel D (10% Owner) Buy 355,000 17.00 6,035,000
2017-10-10 Barris Peter J (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Pfizer Inc (10% Owner) Buy 40,000 17.00 680,000
2017-10-05 Baker Julian (Other) Buy 885,000 17.00 15,045,000

Insider trading activities including stock purchases, stock sales, and option exercises of RYTM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rhythm Pharmaceuticals, Inc. (symbol RYTM, CIK number 1649904) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month